At the time of writing, Petros Pharmaceuticals Inc [PTPI] stock is trading at $1.65, down -0.60%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PTPI shares have gain 7.14% over the last week, with a monthly amount glided 43.48%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 14, February 2024, Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider. In a post published today on Yahoo Finance, AI software expected to further enable Petros’s efforts to make STENDRA the first ED product to be offered over the counter.
From an analyst’s perspective:
For the past year, the stock price of Petros Pharmaceuticals Inc fluctuated between $0.92 and $9.54. Petros Pharmaceuticals Inc [NASDAQ: PTPI] shares were valued at $1.65 at the most recent close of the market.
Analyzing the PTPI fundamentals
According to Petros Pharmaceuticals Inc [NASDAQ:PTPI], the company’s sales were 6.98M for trailing twelve months, which represents an 214.88% jump. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5900 points at the first support level, and at 1.5300 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7000, and for the 2nd resistance point, it is at 1.7500.
Ratios To Look Out For
It is important to note that Petros Pharmaceuticals Inc [NASDAQ:PTPI] has a current ratio of 3.02. Further, the Quick Ratio stands at 2.71, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 0.52, the price to book ratio is 0.50.
Transactions by insiders
Insider trading, which has resulted in 1 insider purchases of 49,645 shares and 0 insider sales of 0 shares in the past three months, is now the topic of our analysis.
